Autoimmune Hepatitis in Iran: What We Know, What We Don’t Know and Requirements for Better Management

AUTHORS

Mostafa shafiei 1 , Seyed Moayed Alavian 1 , *

1 Baqiyatallah Research Center for Gastroenterology and Liver diseases, Baqiyatallah University of Medical Sciences, Tehran, IR Iran

How to Cite: shafiei M, Alavian S M. Autoimmune Hepatitis in Iran: What We Know, What We Don’t Know and Requirements for Better Management, Hepat Mon. 2012 ; 12(2):e93033. doi: 10.5812/hepatmon.840.

ARTICLE INFORMATION

Hepatitis Monthly: 12 (2); e93033
Published Online: February 29, 2012
Article Type: Editorial
Received: May 06, 2019
Accepted: February 29, 2012
Crossmark

Crossmark

CHEKING

READ FULL TEXT
Abstract

Autoimmune hepatitis is a quite serious disease, and will get worse if not treated properly. AIH is a disease that needs to be managed under the supervision of a team of specialists, including at least one hepatologist or a gastroenterologist with an interest in liver disease, as well as a laboratory that can measure all serum autoantibodies with accurate titres. This article is highly recommended to hepatologists, gastroenterologists, virologists, general practitioners, and researchers who are interested in public health.

Please cite this paper as:
Shafiei M, Alavian SM. Autoimmune Hepatitis in Iran: What We Know, What We Don't Know and Requirements for Better Management. Hepat Mon. 2012;12(2):73-6. DOI: 10.5812/hepatmon.840

Keywords

hepatitis

© 2012, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Fulltext

References

  • 1.

    The references are available in the PDF file.

  • COMMENTS

    LEAVE A COMMENT HERE: